138 related articles for article (PubMed ID: 18025188)
1. Murine lupus susceptibility locus Sle1a controls regulatory T cell number and function through multiple mechanisms.
Cuda CM; Wan S; Sobel ES; Croker BP; Morel L
J Immunol; 2007 Dec; 179(11):7439-47. PubMed ID: 18025188
[TBL] [Abstract][Full Text] [Related]
2. Murine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cells.
Cuda CM; Zeumer L; Sobel ES; Croker BP; Morel L
Genes Immun; 2010 Oct; 11(7):542-53. PubMed ID: 20445563
[TBL] [Abstract][Full Text] [Related]
3. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c.
Chen Y; Perry D; Boackle SA; Sobel ES; Molina H; Croker BP; Morel L
J Immunol; 2005 Jul; 175(2):1080-9. PubMed ID: 16002709
[TBL] [Abstract][Full Text] [Related]
4. Genetic determination of T cell help in loss of tolerance to nuclear antigens.
Chen Y; Cuda C; Morel L
J Immunol; 2005 Jun; 174(12):7692-702. PubMed ID: 15944270
[TBL] [Abstract][Full Text] [Related]
5. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions.
Wan S; Xia C; Morel L
J Immunol; 2007 Jan; 178(1):271-9. PubMed ID: 17182564
[TBL] [Abstract][Full Text] [Related]
6. The major murine systemic lupus erythematosus susceptibility locus Sle1 results in abnormal functions of both B and T cells.
Sobel ES; Satoh M; Chen Y; Wakeland EK; Morel L
J Immunol; 2002 Sep; 169(5):2694-700. PubMed ID: 12193743
[TBL] [Abstract][Full Text] [Related]
7. Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production.
Rahman ZS; Niu H; Perry D; Wakeland E; Manser T; Morel L
Genes Immun; 2007 Oct; 8(7):604-12. PubMed ID: 17713556
[TBL] [Abstract][Full Text] [Related]
8. Pre-B cell leukemia homeobox 1 is associated with lupus susceptibility in mice and humans.
Cuda CM; Li S; Liang S; Yin Y; Potula HH; Xu Z; Sengupta M; Chen Y; Butfiloski E; Baker H; Chang LJ; Dozmorov I; Sobel ES; Morel L
J Immunol; 2012 Jan; 188(2):604-14. PubMed ID: 22180614
[TBL] [Abstract][Full Text] [Related]
9. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
10. Genetic dissection of systemic lupus erythematosus pathogenesis: partial functional complementation between Sle1 and Sle3/5 demonstrates requirement for intracellular coexpression for full phenotypic expression of lupus.
Wakui M; Morel L; Butfiloski EJ; Kim C; Sobel ES
J Immunol; 2005 Jul; 175(2):1337-45. PubMed ID: 16002739
[TBL] [Abstract][Full Text] [Related]
11. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.
Wu HY; Quintana FJ; Weiner HL
J Immunol; 2008 Nov; 181(9):6038-50. PubMed ID: 18941193
[TBL] [Abstract][Full Text] [Related]
12. Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells.
Sobel ES; Mohan C; Morel L; Schiffenbauer J; Wakeland EK
J Immunol; 1999 Feb; 162(4):2415-21. PubMed ID: 9973523
[TBL] [Abstract][Full Text] [Related]
13. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
14. Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells.
Sobel ES; Morel L; Baert R; Mohan C; Schiffenbauer J; Wakeland EK
J Immunol; 2002 Oct; 169(7):4025-32. PubMed ID: 12244205
[TBL] [Abstract][Full Text] [Related]
15. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
17. Increased CD4
Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L
Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752
[TBL] [Abstract][Full Text] [Related]
18. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
19. Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus.
Croker BP; Gilkeson G; Morel L
Genes Immun; 2003 Dec; 4(8):575-85. PubMed ID: 14647198
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
